Amalgamated Bank’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$644K Buy
+60,103
New +$465K ﹤0.01% 1285
2026
Q1
Sell
-5,225
Closed -$37K 2282
2025
Q4
$37K Buy
5,225
+395
+8% +$2.38K ﹤0.01% 1907
2025
Q3
$27K Hold
4,830
﹤0.01% 2010
2025
Q2
$25K Hold
4,830
﹤0.01% 2029
2025
Q1
$32K Buy
4,830
+1,215
+34% +$9.24K ﹤0.01% 1915
2024
Q4
$27K Hold
3,615
﹤0.01% 2012
2024
Q3
$25K Hold
3,615
﹤0.01% 2047
2024
Q2
$18K Hold
3,615
﹤0.01% 2169
2024
Q1
$22K Sell
3,615
-8,818
-71% -$59.4K ﹤0.01% 2093
2023
Q4
$97K Sell
12,433
-1,076
-8% -$6.94K ﹤0.01% 2009
2023
Q3
$93K Buy
13,509
+1,437
+12% +$11.6K ﹤0.01% 2028
2023
Q2
$110K Buy
12,072
+4,307
+55% +$35.8K ﹤0.01% 2028
2023
Q1
$58K Sell
7,765
-1,546
-17% -$8.57K ﹤0.01% 2249
2022
Q4
$46K Hold
9,311
﹤0.01% 2453
2022
Q3
$62K Buy
9,311
+11
+0.1% +$77 ﹤0.01% 2365
2022
Q2
$52K Buy
9,300
+1,018
+12% +$7.8K ﹤0.01% 2458
2022
Q1
$84K Buy
+8,282
New +$72.7K ﹤0.01% 2263

Other funds holding LFST

Amalgamated Bank's LFST Position: Q2 2026 in Review

Amalgamated Bank opened a new position in Lifestance Health (LFST) in Q2 2026: 60,103 shares worth $644K. The stake represents ﹤0.01% of the portfolio and ranks #1285 among its holdings. This is a return to the name: Amalgamated Bank previously reported a position in LFST as recently as Q4 2025.

Amalgamated Bank first reported a position in LFST in Q1 2022 and has held it in 17 quarters since. 120 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Amalgamated Bank held 60,103 shares of Lifestance Health worth $644K as of Q2 2026.
  • Lifestance Health was a new Amalgamated Bank position in Q2 2026.
  • Lifestance Health made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1285 holding.
  • Amalgamated Bank first reported a position in Lifestance Health in Q1 2022 and has held it in 17 quarters since.
  • 120 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.